[S-39] Symposium 39
The concept of MOG-IgG positive diseases

[S-39-5] Pediatric cases of MOG-IgG disease

^○Takahiro Ikeda, Takanori Yamagata (Department of Pediatrics, Jichi Medical University, Japan)

Auto-antibodies (IgG) against myelin oligodendrocyte glycoprotein (MOG) are detected in the serum of patients with various demyelinating diseases. These patients are known to show repeated clinical episodes of inflammatory demyelinating attacks in the central nervous system. Although the associated pathogenicity and mechanism of inflammatory demyelination remains inconclusive, it is known that patients with MOG-IgG have a different clinical spectrum from those with other demyelinating diseases, such as multiple sclerosis. We conducted this symposium to understand the clinical features and the spectrum of MOG-IgG related demyelinating diseases.

EDUCATION/POST GRADUATE TRAINING
2001-2007　M.D., Toho university, Tokyo, Japan
2014-2019　Ph.D., Jichi medical university, Tochigi, Japan
Residency:
2007-2009 Resident, Jichi medical university, Tochigi, Japan
Fellowship:
2009-2012 Fellow in pediatrics, Jichi medical university, Tochigi, Japan
BOARD CERTIFICATION
Dec 2012　Board Certified Member of the Japan Pediatric Society
Jan 2020　Board Certified Member of the Japanese Society of Child Neurology
PRESENT POSITION
2012-present
Assistant Professor Department of Pediatrics, Jichi medical university
AWARDS
May 2019 Excellent presentation award in 61st Annual Meeting of the Japanese Society of Child Neurology